title: Meeting commentary--"Parkinson's disease: From patient to product".
abstract: A meeting organised by the Academy of Pharmaceutical Sciences (APSGB) Age-Related Medicines Focus Group took place on the 19th of May 2015, in GlaxoSmithKline Ware, UK [*]. The meeting was the first of a planned series of disease specific meetings organised by APSGB. It was attended by a number of experts involved with the treatment and development of drugs for the older adult, including clinicians, pharmacists, academics, regulators and representatives from industry. The event created the platform to discuss the provision of medicines for the treatment of Parkinson's disease (PD) from a pharmaceutical sciences perspective. 'Medications are something you prescribe: something that gives me my life back' (A PD sufferer).
authors.affiliation: The Academy of Pharmaceutical Sciences, Q House, Troon Way Business Centre, Humberstone Lane, Thurmaston, Leicester LE4 9HA, UK. Electronic address: john.wahlich@btinternet.com.
authors.forename: John
authors.initials: J
authors.lastname: Wahlich
authors.affiliation: PD UK, RD Platform Technology & Science, GSK, Ware, Hertfordshire SG12 0DP, UK. Electronic address: David.P.Elder@gsk.com.
authors.forename: David
authors.initials: D
authors.lastname: Elder
authors.affiliation: University of Hertfordshire, Department of Pharmacy, Pharmacology and Postgraduate Medicine, Hatfield, Hertfordshire AL10 9AB, UK. Electronic address: f.liu3@herts.ac.uk.
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
authors.affiliation: Queen's University Belfast, School of Pharmacy, Belfast, Northern Ireland BT7 1NN, UK. Electronic address: c.hughes@qub.ac.uk.
authors.forename: Carmel
authors.initials: C
authors.lastname: Hughes
authors.affiliation: University College London, School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK. Electronic address: m.gul@ucl.ac.uk.
authors.forename: Mine
authors.initials: M
authors.lastname: Orlu-Gul
mesh_terms: D000978:Antiparkinson Agents / Q000737:chemistry* / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D004364:Pharmaceutical Preparations / Q000737:chemistry*
chemical_list: D000978:Antiparkinson Agents; D004364:Pharmaceutical Preparations
keywords: Dosage form; Formulation; Medicine; Older adult; Parkinson’s disease